Patient-Reported Outcomes of Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large-Cell Lymphoma
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s96175
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2016
Authors
Publisher
Informa UK Limited